Reversible occlusion (on–off) valves in shunted tumor patients

[1]  E. Thiel,et al.  Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma , 2009, Annals of Hematology.

[2]  K. Hess,et al.  Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. , 2008, Neuro-oncology.

[3]  N. Harbeck,et al.  Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. , 2008, Anti-cancer drugs.

[4]  M. Gilbert,et al.  A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. , 2008, Neuro-oncology.

[5]  M. Murawska,et al.  Breast cancer leptomeningeal metastasis—the role of multimodality treatment , 2007, Journal of Neuro-Oncology.

[6]  J. van Lunzen,et al.  AIDS-associated Burkitt or Burkitt-like lymphoma: Short intensive polychemotherapy is feasible and effective , 2006, Leukemia & lymphoma.

[7]  S. Phuphanich,et al.  Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Hainfellner,et al.  Reversible occlusion shunt for intraventricular chemotherapy in shunt-dependent brain tumor patients. , 1997, Pediatric hematology and oncology.

[9]  Gerber Am.  Malfunction of multipurpose valve shunt. , 1977 .

[10]  H. Portnoy,et al.  Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. , 1973, Journal of neurosurgery.

[11]  K. Osaka,et al.  [Efficiency of the on-off valve in the cerebrospinal fluid shunt (author's transl)]. , 1976, Nihon geka hokan. Archiv fur japanische Chirurgie.